Creatine and Creatinine Metabolism - Physiological Reviews

1210 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
muscle of creatine kinase-deficient mice. Am J Physiol Cell
Physiol 274: C1411–C1416, 1998.
1027. TURNER DM AND WALKER JB. Enhanced ability of skeletal muscle
containing cyclocreatine phosphate to sustain ATP levels during
ischemia following �-adrenergic stimulation. J Biol Chem 262:
6605–6609, 1987.
1028. TURNER DM AND WALKER JB. Relative abilities of phosphagens
with different thermodynamic or kinetic properties to help sustain
ATP and total adenylate pools in heart during ischemia. Arch
Biochem Biophys 238: 642–651, 1985.
1029. TWORT FW AND MELLANBY E. On creatin-destroying Bacilli in
the intestine, and their isolation. J Physiol (Lond) 44: 43–49, 1912.
1030. URDAL P, URDAL K, AND STRØMME JH. Cytoplasmic creatine
kinase isoenzymes quantitated in tissue specimens obtained at
surgery. Clin Chem 29: 310–313, 1983.
1031. USHIYAMA H, WAKABAYASHI K, HIROSE M, ITOH H, SUG-
IMURA T, AND NAGAO M. Presence of carcinogenic heterocyclic
amines in urine of healthy volunteers eating normal diet, but not
of inpatients receiving parenteral alimentation. Carcinogenesis
12: 1417–1422, 1991.
1032. USUI T, YOSHIDA M, ABE K, OSADA H, ISONO K, AND BEPPU T.
Uncoupled cell cycle without mitosis induced by a protein kinase
inhibitor, K-252a. J Cell Biol 115: 1275–1282, 1991.
1033. UWAJIMA T AND TERADA O. Properties of crystalline creatinine
deiminase from Corynebacterium lilium. Agric Biol Chem 44:
1787–1792, 1980.
1034. VAINIO P, USENIUS JP, VAPALAHTI M, PARTANEN K, KÄLVI-
ÄINEN R, RINNE J, AND KAUPPINEN RA. Reduced N-acetylaspartate
concentration in temporal lobe epilepsy by quantitative 1 H
MRS in vivo. Neuroreport 5: 1733–1736, 1994.
1035. VANAKOSKI J, KOSUNEN V, MERIRINNE E, AND SEPPÄLÄ T.
Creatine and caffeine in anaerobic and aerobic exercise: effects
on physical performance and pharmacokinetic considerations. Int
J Clin Pharmacol Ther 36: 258–263, 1998.
1036. VAN BELLE H, WYNANTS J, XHONNEUX R, AND FLAMENG W.
Changes in creatine phosphate, inorganic phosphate, and the
purine pattern in dog hearts with time of coronary artery occlusion
and effect thereon of mioflazine, a nucleoside transport
inhibitor. Cardiovasc Res 20: 658–664, 1986.
1037. VAN BILSEN M, VAN DER VUSSE GJ, COUMANS WA, DE
GROOT MJM, WILLEMSEN PHM, AND RENEMAN RS. Degradation
of adenine nucleotides in ischemic and reperfused rat heart.
Am J Physiol Heart Circ Physiol 257: H47–H54, 1989.
1038. VANDEBUERIE F, VANDEN EYNDE B, VANDENBERGHE K, AND
HESPEL P. Effect of creatine loading on endurance capacity and
sprint power in cyclists. Int J Sports Med 19: 490–495, 1998.
1039. VANDENBERGHE K, GILLIS N, VAN LEEMPUTTE M, VAN
HECKE P, VANSTAPEL F, AND HESPEL P. Caffeine couteracts the
ergogenic action of muscle creatine loading. J Appl Physiol 80:
452–457, 1996.
1040. VANDENBERGHE K, GORIS M, VAN HECKE P, VAN LEEM-
PUTTE M, VANGERVEN L, AND HESPEL P. Long-term creatine
intake is beneficial to muscle performance during resistance training.
J Appl Physiol 83: 2055–2063, 1997.
1041. VANDENBERGHE K, VAN HECKE P, VAN LEEMPUTTE M, VAN-
STAPEL F, AND HESPEL P. Phosphocreatine resynthesis is not
affected by creatine loading. Med Sci Sports Exercise 31: 236–242,
1999.
1042. VANDENBORNE K, WALTER G, PLOUTZ-SNYDER L, STARON R,
FRY A, DE MEIRLEIR K, DUDLEY GA, AND LEIGH JS. Energy-rich
phosphates in slow and fast human skeletal muscle. Am J Physiol
Cell Physiol 268: C869–C876, 1995.
1043. VAN DEURSEN J, HEERSCHAP A, OERLEMANS F, RUITEN-
BEEK W, JAP P, TER LAAK H, AND WIERINGA B. Skeletal muscles
of mice deficient in muscle creatine kinase lack burst activity.
Cell 74: 621–631, 1993.
1044. VAN DEURSEN J, JAP P, HEERSCHAP A, TER LAAK H, RUITEN-
BEEK W, AND WIERINGA B. Effects of the creatine analogue
�-guanidinopropionic acid on skeletal muscles of mice deficient in
muscle creatine kinase. Biochim Biophys Acta 1185: 327–335,
1994.
1045. VAN DEURSEN J, RUITENBEEK W, HEERSCHAP A, JAP P, TER
LAAK H, AND WIERINGA B. Creatine kinase (CK) in skeletal
muscle energy metabolism: a study of mouse mutants with graded
reduction in muscle CK expression. Proc Natl Acad Sci USA 91:
9091–9095, 1994.
1046. VAN DOMBURG PHMF, GABREËLS-FESTEN AAWM, GABREËLS
FJM, DE COO R, RUITENBEEK W, WESSELING P, AND TER LAAK
H. Mitochondrial cytopathy presenting as hereditary sensory neuropathy
with progressive external ophthalmoplegia, ataxia and fatal
myoclonic epileptic status. Brain 119: 997–1010, 1996.
1047. VAN DORSTEN FA, NEDERHOFF MGJ, NICOLAY K, AND VAN
ECHTELD CJA. 31 P NMR studies of creatine kinase flux in Mcreatine
kinase-deficient mouse heart. Am J Physiol Heart Circ
Physiol 275: H1191–H1199, 1998.
1048. VAN DORSTEN FA, REESE T, GELLERICH JF, VAN ECHTELD
CJA, NEDERHOFF MGJ, MULLER H-J, VAN VLIET G, AND NICO-
LAY K. Fluxes through cytosolic and mitochondrial creatine kinase,
measured by P-31 NMR. Mol Cell Biochem 174: 33–42, 1997.
1049. VAN EYK HG, VERMAAT RJ, LEIJNSE-YBEMA HJ, AND LEIJNSE
B. The conversion of creatinine by creatininase of bacterial origin.
Enzymologia 34: 198–202, 1968.
1050. VAN HOOGENHUYZE CJC AND VERPLOEGH H. Beobachtungen
über die Kreatininausscheidung beim Menschen. Zschr Physiol
Chem 46: 415–471, 1905.
1051. VAN LEEMPUTTE M, VANDENBERGHE K, AND HESPEL P.
Shortening of muscle relaxation time after creatine loading.
J Appl Physiol 86: 840–844, 1999.
1052. VANNAS-SULONEN K, SIPILÄ I, VANNAS A, SIMELL O, AND
RAPOLA J. Gyrate atrophy of the choroid and retina. A five-year
follow-up of creatine supplementation. Ophthalmology 92: 1719–
1727, 1985.
1053. VAN PILSUM JF, MCGUIRE DM, AND MILLER CA. The antagonistic
action of creatine and growth hormone on the expression of
the gene for rat kidney L-arginine:glycine amidinotransferase. In:
Guanidino Compounds in Biology and Medicine, edited by P. P.
De Deyn, B. Marescau, V. Stalon, and I. A. Qureshi. London:
Libbey, 1992, p. 147–151.
1054. VAN PILSUM JF, MCGUIRE DM, AND TOWLE H. On the mechanism
of the alterations of rat kidney transamidinase activities by
diet and hormones. In: Urea Cycle Diseases, edited by A. Lowenthal,
A. Mori, and B. Marescau. New York: Plenum, 1982, p.
291–297.
1055. VAN PILSUM JF, OLSEN B, TAYLOR D, ROZYCKI T, AND PIERCE
JC. Transamidinase activities, in vitro, of tissues from various
mammals and from rats fed protein-free, creatine-supplemented
and normal diets. Arch Biochem Biophys 100: 520–524, 1963.
1056. VAN PILSUM JF, STEPHENS GC, AND TAYLOR D. Distribution of
creatine, guanidinoacetate and the enzymes for their biosynthesis
in the animal kingdom. Biochem J 126: 325–345, 1972.
1057. VAN PILSUM JF AND WAHMAN RE. Creatine and creatinine in the
carcass and urine of normal and vitamin E-deficient rabbits. J Biol
Chem 235: 2092–2094, 1960.
1058. VEKSLER V AND VENTURA-CLAPIER R. In situ study of myofibrils,
mitochondria and bound creatine kinases in experimental
cardiomyopathies. Mol Cell Biochem 133: 287–298, 1994.
1059. VEKSLER V AND VENTURA-CLAPIER R. Ischaemic metabolic
factors—high inorganic phosphate and acidosis—modulate mitochondrial
creatine kinase functional activity in skinned cardiac
fibres. J Mol Cell Cardiol 26: 335–339, 1994.
1060. VEKSLER VI, MURAT I, AND VENTURA-CLAPIER R. Creatine
kinase and mechanical and mitochondrial functions in hereditary
and diabetic cardiomyopathies. Can J Physiol Pharmacol 69:
852–858, 1991.
1061. VENTURA-CLAPIER R AND VASSORT G. Electrical and mechanical
activities of frog heart during energetic deficiency. J Muscle
Res Cell Motil 1: 429–444, 1980.
1062. VENTURA-CLAPIER R, VEKSLER VK, ELIZAROVA GV, MEKHFI
H, LEVITSKAYA EL, AND SAKS VA. Contractile properties and
creatine kinase activity of myofilaments following ischemia and
reperfusion of the rat heart. Biochem Med Metab Biol 38: 300–310,
1987.
1063. VIAL C, FONT B, GOLDSCHMIDT D, PEARLMAN AS, AND DE-
LAYE J. Regional myocardial energetics during brief periods of
coronary occlusion and reperfusion: comparison with S-T segment
changes. Cardiovasc Res 12: 470–476, 1978.